Skip to main content
. 2024 Jun 4;14:1394070. doi: 10.3389/fcimb.2024.1394070

Figure 1.

Figure 1

Experimental scheme showing interventions and analytics performed to monitor bacteriological and immunological parameters. The animals were divided in groups of n = 5: non-challenged control (NC), challenged control (CC), commercial vaccine (Silirum®) (CV), commercial vaccine + probiotic (CV-PR), and probiotic (PR) and sampled for different techniques before treatment (BT) and at different time points post-treatment (PT1–PT4).